Enanta Pharmaceuticals, Inc.
$13.60
-0.20 (-1.45%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +4.6%
- 3 Months
- +3.3%
- YTD
- -13.8%
- 1 Year
- +59.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 107.8%
- Largest decline max drawdown, since Aug 2025
- -34.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.83
Own ENTA?
See how ENTA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.